Ozdemir, N. Et Al. 2014. Efficacy and safety of first line Vincristine with doxorubicin, bleomycin and dacarbazine (ABOD) for Hodgkin's lymphoma: A single Institute experience. Asian Pacific Journal of Cancer Prevention , vol.15, no.20 , 8715-8718.

Ozdemir, N., Dogan, M., ŞENDUR, M. A. N., Yazici, O., Abali, H., Yazilitas, D., ... AKINCI, M. B.(2014). Efficacy and safety of first line Vincristine with doxorubicin, bleomycin and dacarbazine (ABOD) for Hodgkin's lymphoma: A single Institute experience. Asian Pacific Journal of Cancer Prevention , vol.15, no.20, 8715-8718.

Ozdemir, Nuriye Et Al. "Efficacy and safety of first line Vincristine with doxorubicin, bleomycin and dacarbazine (ABOD) for Hodgkin's lymphoma: A single Institute experience," Asian Pacific Journal of Cancer Prevention , vol.15, no.20, 8715-8718, 2014

Ozdemir, Nuriye Et Al. "Efficacy and safety of first line Vincristine with doxorubicin, bleomycin and dacarbazine (ABOD) for Hodgkin's lymphoma: A single Institute experience." Asian Pacific Journal of Cancer Prevention , vol.15, no.20, pp.8715-8718, 2014

Ozdemir, N. Et Al. (2014) . "Efficacy and safety of first line Vincristine with doxorubicin, bleomycin and dacarbazine (ABOD) for Hodgkin's lymphoma: A single Institute experience." Asian Pacific Journal of Cancer Prevention , vol.15, no.20, pp.8715-8718.

@article{article, author={Nuriye Ozdemir Et Al. }, title={Efficacy and safety of first line Vincristine with doxorubicin, bleomycin and dacarbazine (ABOD) for Hodgkin's lymphoma: A single Institute experience}, journal={Asian Pacific Journal of Cancer Prevention}, year=2014, pages={8715-8718} }